Noul Co

Noul Co Current Liabilities

The Current Liabilities of Noul Co (376930.KQ) as of Oct 30, 2026 is 121.27 M KRW. In the previous year, Current Liabilities was 7.73 B KRW — a change of -98.43% (lower).

Current Liabilities

121.27 MKRW

YoY

-98.43%

Last updated:

Current Liabilities of Noul Co is 2025 121.27 M KRW. Current Liabilities of Noul Co was 2024 7.73 B KRW. It decreases by -98.43% lower compared to the previous year.

The Noul Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
757.29 M KRW
Jan 1, 2020
1.82 B KRW
Jan 1, 2021
2.46 B KRW
Jan 1, 2022
5.71 B KRW
Jan 1, 2023
3.57 B KRW
Jan 1, 2024
7.73 B KRW
Jan 1, 2025
121.27 M KRW
The Noul Co Current Liabilities history
YEARCurrent LiabilitiesYoY
121.27 MKRW-98.43%
7.73 BKRW+116.59%
3.57 BKRW-37.51%
5.71 BKRW+131.98%
2.46 BKRW+35.21%
1.82 BKRW+140.53%
757.29 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Noul Co Stock analysis

What does Noul Co do? Noul Co., Ltd. generates revenue through the manufacture and sale of blood test diagnostic devices utilizing AI algorithms and diagnostic kits. The company offers regular monthly subscriptions via its integrated web-based remote diagnosis system, targeting healthcare providers and medical facilities seeking advanced diagnostic solutions. Its core products include AI-based diagnostic devices and associated kits, sold directly to clinics and hospitals for use in blood testing procedures. The firm's services are designed to enhance diagnostic accuracy and efficiency through remote access and subscription models. The company's primary revenue streams stem from the sale of physical diagnostic devices and diagnostic kits, alongside recurring subscription fees for its web-based remote diagnosis platform. Healthcare institutions and medical professionals form the key customer segments, purchasing both the hardware and ongoing service access. Noul Co., Ltd. focuses on delivering AI-driven diagnostic tools that integrate seamlessly into existing healthcare workflows, emphasizing convenience and technological innovation for its clients. Noul Co., Ltd. operates exclusively within the healthcare diagnostics sector, providing AI-powered blood test solutions that combine hardware sales with subscription-based software services. The business model relies on initial device purchases followed by continuous revenue from monthly subscriptions, creating a sustainable income stream. This approach ensures long-term engagement with healthcare providers while maintaining a focus on cutting-edge diagnostic technology. Noul Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Noul Co stock

Current Liabilities of Noul Co is 121.27 M KRW in 2025.

Current Liabilities of Noul Co changed from 7.73 B KRW to 121.27 M KRW, representing a -98.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Noul Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Noul Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Noul Co

All Key Metrics — Noul Co